Bespak
Bespak is a global CDMO focused on inhaled and nasal drug delivery devices and drug-device combination products. The company’s service offering spans early-stage feasibility, analytical services, and product development.
Associated Companies
Recipharm
Headquarters
Bespak Europe Ltd
London Road
Holmes Chapel
Crewe
Cheshire
CW4 8BE
United Kingdom
Bespak is a global CDMO focused on inhaled and nasal drug delivery devices and drug-device combination products. The company’s service offering spans early-stage feasibility, analytical services, and product development, from pilot-scale, through to clinical supply and commercial-scale drug product fill-finish, device, and component manufacturing.
The company has made significant investments in commercial-scale and pilot-scale filling equipment for the manufacture of pMDIs using low GWP propellants and is the first CDMO to manufacture a pMDI at commercial scale with HFO-1234ze.
Bespak was founded in 1959, as a supplier of valves for the cosmetics and consumer markets. By 2020 it has become a major supplier of pulmonary and nasal drug delivery devices, valves and actuators, injectable devices and medical check valves into major European and US markets. At that time, the company moulded around 2.6 billion components annually, which were assembled into approximately 550 million devices. In February 2020, Recipharm acquired Consort Medical (UK), including the Bespak division. Bespak was subsequently spun out from Recipharm to become a separate entity again in 2024.
Articles by Bespak
